Global Plasma Derived Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Plasma Derived Medicine market size was valued at USD 2357.4 million in 2023 and is forecast to a readjusted size of USD 3902 million by 2030 with a CAGR of 7.5% during review period.
Plasma Derived Medicine is any therapeutic substance prepared from human blood.
The Global Info Research report includes an overview of the development of the Plasma Derived Medicine industry chain, the market status of Bleeding Wound (Albumin, Immune Globulin), Immunodeficiency (Albumin, Immune Globulin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Plasma Derived Medicine.
Regionally, the report analyzes the Plasma Derived Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Plasma Derived Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Plasma Derived Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Plasma Derived Medicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Bottles), revenue generated, and market share of different by Type (e.g., Albumin, Immune Globulin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Plasma Derived Medicine market.
Regional Analysis: The report involves examining the Plasma Derived Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Plasma Derived Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Plasma Derived Medicine:
Company Analysis: Report covers individual Plasma Derived Medicine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Plasma Derived Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Bleeding Wound, Immunodeficiency).
Technology Analysis: Report covers specific technologies relevant to Plasma Derived Medicine. It assesses the current state, advancements, and potential future developments in Plasma Derived Medicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Plasma Derived Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Plasma Derived Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Plasma Derived Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma Derived Medicine, with price, sales, revenue and global market share of Plasma Derived Medicine from 2019 to 2024.
Chapter 3, the Plasma Derived Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Derived Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Plasma Derived Medicine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma Derived Medicine.
Chapter 14 and 15, to describe Plasma Derived Medicine sales channel, distributors, customers, research findings and conclusion.
Plasma Derived Medicine is any therapeutic substance prepared from human blood.
The Global Info Research report includes an overview of the development of the Plasma Derived Medicine industry chain, the market status of Bleeding Wound (Albumin, Immune Globulin), Immunodeficiency (Albumin, Immune Globulin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Plasma Derived Medicine.
Regionally, the report analyzes the Plasma Derived Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Plasma Derived Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Plasma Derived Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Plasma Derived Medicine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Bottles), revenue generated, and market share of different by Type (e.g., Albumin, Immune Globulin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Plasma Derived Medicine market.
Regional Analysis: The report involves examining the Plasma Derived Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Plasma Derived Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Plasma Derived Medicine:
Company Analysis: Report covers individual Plasma Derived Medicine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Plasma Derived Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Bleeding Wound, Immunodeficiency).
Technology Analysis: Report covers specific technologies relevant to Plasma Derived Medicine. It assesses the current state, advancements, and potential future developments in Plasma Derived Medicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Plasma Derived Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Plasma Derived Medicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
- Bleeding Wound
- Immunodeficiency
- HBV
- Tetanus
- Rabies
- Hemophilia
- Others
- Takeda
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- Shanghai RAAS
- China Biologic Products
- Hualan Biological Engineering Inc.
- Beijing Tiantan Biological Products Corp
- Pacific Shuanglin
- Boya Bio-Pharmaceutical
- Paisi Feike Biology Pharmacy Co., Ltd.
- Xinjiang Deyuan Bioengineering
- Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
- Shenzhen Weiguang
- Shanxi Kangbao
- Nanyue Biopharming Corporation Ltd
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Plasma Derived Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma Derived Medicine, with price, sales, revenue and global market share of Plasma Derived Medicine from 2019 to 2024.
Chapter 3, the Plasma Derived Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma Derived Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Plasma Derived Medicine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma Derived Medicine.
Chapter 14 and 15, to describe Plasma Derived Medicine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Plasma Derived Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plasma Derived Medicine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Albumin
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Plasma Derived Medicine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Bleeding Wound
1.4.3 Immunodeficiency
1.4.4 HBV
1.4.5 Tetanus
1.4.6 Rabies
1.4.7 Hemophilia
1.4.8 Others
1.5 Global Plasma Derived Medicine Market Size & Forecast
1.5.1 Global Plasma Derived Medicine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Plasma Derived Medicine Sales Quantity (2019-2030)
1.5.3 Global Plasma Derived Medicine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma Derived Medicine Product and Services
2.1.4 Takeda Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma Derived Medicine Product and Services
2.2.4 CSL Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Recent Developments/Updates
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma Derived Medicine Product and Services
2.3.4 Grifols Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Grifols Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma Derived Medicine Product and Services
2.4.4 Octapharma Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Octapharma Recent Developments/Updates
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma Derived Medicine Product and Services
2.5.4 Kedrion Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Kedrion Recent Developments/Updates
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma Derived Medicine Product and Services
2.6.4 LFB Group Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 LFB Group Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma Derived Medicine Product and Services
2.7.4 Biotest Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotest Recent Developments/Updates
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma Derived Medicine Product and Services
2.8.4 BPL Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BPL Recent Developments/Updates
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Plasma Derived Medicine Product and Services
2.9.4 Shanghai RAAS Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Shanghai RAAS Recent Developments/Updates
2.10 China Biologic Products
2.10.1 China Biologic Products Details
2.10.2 China Biologic Products Major Business
2.10.3 China Biologic Products Plasma Derived Medicine Product and Services
2.10.4 China Biologic Products Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 China Biologic Products Recent Developments/Updates
2.11 Hualan Biological Engineering Inc.
2.11.1 Hualan Biological Engineering Inc. Details
2.11.2 Hualan Biological Engineering Inc. Major Business
2.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Product and Services
2.11.4 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hualan Biological Engineering Inc. Recent Developments/Updates
2.12 Beijing Tiantan Biological Products Corp
2.12.1 Beijing Tiantan Biological Products Corp Details
2.12.2 Beijing Tiantan Biological Products Corp Major Business
2.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product and Services
2.12.4 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Beijing Tiantan Biological Products Corp Recent Developments/Updates
2.13 Pacific Shuanglin
2.13.1 Pacific Shuanglin Details
2.13.2 Pacific Shuanglin Major Business
2.13.3 Pacific Shuanglin Plasma Derived Medicine Product and Services
2.13.4 Pacific Shuanglin Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Pacific Shuanglin Recent Developments/Updates
2.14 Boya Bio-Pharmaceutical
2.14.1 Boya Bio-Pharmaceutical Details
2.14.2 Boya Bio-Pharmaceutical Major Business
2.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Product and Services
2.14.4 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Boya Bio-Pharmaceutical Recent Developments/Updates
2.15 Paisi Feike Biology Pharmacy Co., Ltd.
2.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Details
2.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Major Business
2.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product and Services
2.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
2.16 Xinjiang Deyuan Bioengineering
2.16.1 Xinjiang Deyuan Bioengineering Details
2.16.2 Xinjiang Deyuan Bioengineering Major Business
2.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product and Services
2.16.4 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Xinjiang Deyuan Bioengineering Recent Developments/Updates
2.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
2.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Details
2.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Major Business
2.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product and Services
2.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
2.18 Shenzhen Weiguang
2.18.1 Shenzhen Weiguang Details
2.18.2 Shenzhen Weiguang Major Business
2.18.3 Shenzhen Weiguang Plasma Derived Medicine Product and Services
2.18.4 Shenzhen Weiguang Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Shenzhen Weiguang Recent Developments/Updates
2.19 Shanxi Kangbao
2.19.1 Shanxi Kangbao Details
2.19.2 Shanxi Kangbao Major Business
2.19.3 Shanxi Kangbao Plasma Derived Medicine Product and Services
2.19.4 Shanxi Kangbao Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Shanxi Kangbao Recent Developments/Updates
2.20 Nanyue Biopharming Corporation Ltd
2.20.1 Nanyue Biopharming Corporation Ltd Details
2.20.2 Nanyue Biopharming Corporation Ltd Major Business
2.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product and Services
2.20.4 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Nanyue Biopharming Corporation Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PLASMA DERIVED MEDICINE BY MANUFACTURER
3.1 Global Plasma Derived Medicine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Plasma Derived Medicine Revenue by Manufacturer (2019-2024)
3.3 Global Plasma Derived Medicine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Plasma Derived Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Plasma Derived Medicine Manufacturer Market Share in 2023
3.4.2 Top 6 Plasma Derived Medicine Manufacturer Market Share in 2023
3.5 Plasma Derived Medicine Market: Overall Company Footprint Analysis
3.5.1 Plasma Derived Medicine Market: Region Footprint
3.5.2 Plasma Derived Medicine Market: Company Product Type Footprint
3.5.3 Plasma Derived Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Plasma Derived Medicine Market Size by Region
4.1.1 Global Plasma Derived Medicine Sales Quantity by Region (2019-2030)
4.1.2 Global Plasma Derived Medicine Consumption Value by Region (2019-2030)
4.1.3 Global Plasma Derived Medicine Average Price by Region (2019-2030)
4.2 North America Plasma Derived Medicine Consumption Value (2019-2030)
4.3 Europe Plasma Derived Medicine Consumption Value (2019-2030)
4.4 Asia-Pacific Plasma Derived Medicine Consumption Value (2019-2030)
4.5 South America Plasma Derived Medicine Consumption Value (2019-2030)
4.6 Middle East and Africa Plasma Derived Medicine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Plasma Derived Medicine Sales Quantity by Type (2019-2030)
5.2 Global Plasma Derived Medicine Consumption Value by Type (2019-2030)
5.3 Global Plasma Derived Medicine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Plasma Derived Medicine Sales Quantity by Application (2019-2030)
6.2 Global Plasma Derived Medicine Consumption Value by Application (2019-2030)
6.3 Global Plasma Derived Medicine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Plasma Derived Medicine Sales Quantity by Type (2019-2030)
7.2 North America Plasma Derived Medicine Sales Quantity by Application (2019-2030)
7.3 North America Plasma Derived Medicine Market Size by Country
7.3.1 North America Plasma Derived Medicine Sales Quantity by Country (2019-2030)
7.3.2 North America Plasma Derived Medicine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Plasma Derived Medicine Sales Quantity by Type (2019-2030)
8.2 Europe Plasma Derived Medicine Sales Quantity by Application (2019-2030)
8.3 Europe Plasma Derived Medicine Market Size by Country
8.3.1 Europe Plasma Derived Medicine Sales Quantity by Country (2019-2030)
8.3.2 Europe Plasma Derived Medicine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Plasma Derived Medicine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Plasma Derived Medicine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Plasma Derived Medicine Market Size by Region
9.3.1 Asia-Pacific Plasma Derived Medicine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Plasma Derived Medicine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Plasma Derived Medicine Sales Quantity by Type (2019-2030)
10.2 South America Plasma Derived Medicine Sales Quantity by Application (2019-2030)
10.3 South America Plasma Derived Medicine Market Size by Country
10.3.1 South America Plasma Derived Medicine Sales Quantity by Country (2019-2030)
10.3.2 South America Plasma Derived Medicine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Plasma Derived Medicine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Plasma Derived Medicine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Plasma Derived Medicine Market Size by Country
11.3.1 Middle East & Africa Plasma Derived Medicine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Plasma Derived Medicine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Plasma Derived Medicine Market Drivers
12.2 Plasma Derived Medicine Market Restraints
12.3 Plasma Derived Medicine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Plasma Derived Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma Derived Medicine
13.3 Plasma Derived Medicine Production Process
13.4 Plasma Derived Medicine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plasma Derived Medicine Typical Distributors
14.3 Plasma Derived Medicine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Plasma Derived Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plasma Derived Medicine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Albumin
1.3.3 Immune Globulin
1.3.4 Coagulation Factor
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Plasma Derived Medicine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Bleeding Wound
1.4.3 Immunodeficiency
1.4.4 HBV
1.4.5 Tetanus
1.4.6 Rabies
1.4.7 Hemophilia
1.4.8 Others
1.5 Global Plasma Derived Medicine Market Size & Forecast
1.5.1 Global Plasma Derived Medicine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Plasma Derived Medicine Sales Quantity (2019-2030)
1.5.3 Global Plasma Derived Medicine Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma Derived Medicine Product and Services
2.1.4 Takeda Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma Derived Medicine Product and Services
2.2.4 CSL Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Recent Developments/Updates
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma Derived Medicine Product and Services
2.3.4 Grifols Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Grifols Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma Derived Medicine Product and Services
2.4.4 Octapharma Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Octapharma Recent Developments/Updates
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma Derived Medicine Product and Services
2.5.4 Kedrion Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Kedrion Recent Developments/Updates
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma Derived Medicine Product and Services
2.6.4 LFB Group Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 LFB Group Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma Derived Medicine Product and Services
2.7.4 Biotest Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotest Recent Developments/Updates
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma Derived Medicine Product and Services
2.8.4 BPL Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BPL Recent Developments/Updates
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Plasma Derived Medicine Product and Services
2.9.4 Shanghai RAAS Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Shanghai RAAS Recent Developments/Updates
2.10 China Biologic Products
2.10.1 China Biologic Products Details
2.10.2 China Biologic Products Major Business
2.10.3 China Biologic Products Plasma Derived Medicine Product and Services
2.10.4 China Biologic Products Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 China Biologic Products Recent Developments/Updates
2.11 Hualan Biological Engineering Inc.
2.11.1 Hualan Biological Engineering Inc. Details
2.11.2 Hualan Biological Engineering Inc. Major Business
2.11.3 Hualan Biological Engineering Inc. Plasma Derived Medicine Product and Services
2.11.4 Hualan Biological Engineering Inc. Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hualan Biological Engineering Inc. Recent Developments/Updates
2.12 Beijing Tiantan Biological Products Corp
2.12.1 Beijing Tiantan Biological Products Corp Details
2.12.2 Beijing Tiantan Biological Products Corp Major Business
2.12.3 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product and Services
2.12.4 Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Beijing Tiantan Biological Products Corp Recent Developments/Updates
2.13 Pacific Shuanglin
2.13.1 Pacific Shuanglin Details
2.13.2 Pacific Shuanglin Major Business
2.13.3 Pacific Shuanglin Plasma Derived Medicine Product and Services
2.13.4 Pacific Shuanglin Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Pacific Shuanglin Recent Developments/Updates
2.14 Boya Bio-Pharmaceutical
2.14.1 Boya Bio-Pharmaceutical Details
2.14.2 Boya Bio-Pharmaceutical Major Business
2.14.3 Boya Bio-Pharmaceutical Plasma Derived Medicine Product and Services
2.14.4 Boya Bio-Pharmaceutical Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Boya Bio-Pharmaceutical Recent Developments/Updates
2.15 Paisi Feike Biology Pharmacy Co., Ltd.
2.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Details
2.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Major Business
2.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product and Services
2.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
2.16 Xinjiang Deyuan Bioengineering
2.16.1 Xinjiang Deyuan Bioengineering Details
2.16.2 Xinjiang Deyuan Bioengineering Major Business
2.16.3 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product and Services
2.16.4 Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Xinjiang Deyuan Bioengineering Recent Developments/Updates
2.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
2.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Details
2.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Major Business
2.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product and Services
2.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
2.18 Shenzhen Weiguang
2.18.1 Shenzhen Weiguang Details
2.18.2 Shenzhen Weiguang Major Business
2.18.3 Shenzhen Weiguang Plasma Derived Medicine Product and Services
2.18.4 Shenzhen Weiguang Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Shenzhen Weiguang Recent Developments/Updates
2.19 Shanxi Kangbao
2.19.1 Shanxi Kangbao Details
2.19.2 Shanxi Kangbao Major Business
2.19.3 Shanxi Kangbao Plasma Derived Medicine Product and Services
2.19.4 Shanxi Kangbao Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Shanxi Kangbao Recent Developments/Updates
2.20 Nanyue Biopharming Corporation Ltd
2.20.1 Nanyue Biopharming Corporation Ltd Details
2.20.2 Nanyue Biopharming Corporation Ltd Major Business
2.20.3 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product and Services
2.20.4 Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Nanyue Biopharming Corporation Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PLASMA DERIVED MEDICINE BY MANUFACTURER
3.1 Global Plasma Derived Medicine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Plasma Derived Medicine Revenue by Manufacturer (2019-2024)
3.3 Global Plasma Derived Medicine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Plasma Derived Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Plasma Derived Medicine Manufacturer Market Share in 2023
3.4.2 Top 6 Plasma Derived Medicine Manufacturer Market Share in 2023
3.5 Plasma Derived Medicine Market: Overall Company Footprint Analysis
3.5.1 Plasma Derived Medicine Market: Region Footprint
3.5.2 Plasma Derived Medicine Market: Company Product Type Footprint
3.5.3 Plasma Derived Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Plasma Derived Medicine Market Size by Region
4.1.1 Global Plasma Derived Medicine Sales Quantity by Region (2019-2030)
4.1.2 Global Plasma Derived Medicine Consumption Value by Region (2019-2030)
4.1.3 Global Plasma Derived Medicine Average Price by Region (2019-2030)
4.2 North America Plasma Derived Medicine Consumption Value (2019-2030)
4.3 Europe Plasma Derived Medicine Consumption Value (2019-2030)
4.4 Asia-Pacific Plasma Derived Medicine Consumption Value (2019-2030)
4.5 South America Plasma Derived Medicine Consumption Value (2019-2030)
4.6 Middle East and Africa Plasma Derived Medicine Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Plasma Derived Medicine Sales Quantity by Type (2019-2030)
5.2 Global Plasma Derived Medicine Consumption Value by Type (2019-2030)
5.3 Global Plasma Derived Medicine Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Plasma Derived Medicine Sales Quantity by Application (2019-2030)
6.2 Global Plasma Derived Medicine Consumption Value by Application (2019-2030)
6.3 Global Plasma Derived Medicine Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Plasma Derived Medicine Sales Quantity by Type (2019-2030)
7.2 North America Plasma Derived Medicine Sales Quantity by Application (2019-2030)
7.3 North America Plasma Derived Medicine Market Size by Country
7.3.1 North America Plasma Derived Medicine Sales Quantity by Country (2019-2030)
7.3.2 North America Plasma Derived Medicine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Plasma Derived Medicine Sales Quantity by Type (2019-2030)
8.2 Europe Plasma Derived Medicine Sales Quantity by Application (2019-2030)
8.3 Europe Plasma Derived Medicine Market Size by Country
8.3.1 Europe Plasma Derived Medicine Sales Quantity by Country (2019-2030)
8.3.2 Europe Plasma Derived Medicine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Plasma Derived Medicine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Plasma Derived Medicine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Plasma Derived Medicine Market Size by Region
9.3.1 Asia-Pacific Plasma Derived Medicine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Plasma Derived Medicine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Plasma Derived Medicine Sales Quantity by Type (2019-2030)
10.2 South America Plasma Derived Medicine Sales Quantity by Application (2019-2030)
10.3 South America Plasma Derived Medicine Market Size by Country
10.3.1 South America Plasma Derived Medicine Sales Quantity by Country (2019-2030)
10.3.2 South America Plasma Derived Medicine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Plasma Derived Medicine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Plasma Derived Medicine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Plasma Derived Medicine Market Size by Country
11.3.1 Middle East & Africa Plasma Derived Medicine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Plasma Derived Medicine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Plasma Derived Medicine Market Drivers
12.2 Plasma Derived Medicine Market Restraints
12.3 Plasma Derived Medicine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Plasma Derived Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma Derived Medicine
13.3 Plasma Derived Medicine Production Process
13.4 Plasma Derived Medicine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plasma Derived Medicine Typical Distributors
14.3 Plasma Derived Medicine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Plasma Derived Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Plasma Derived Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma Derived Medicine Product and Services
Table 6. Takeda Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Plasma Derived Medicine Product and Services
Table 11. CSL Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Recent Developments/Updates
Table 13. Grifols Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Major Business
Table 15. Grifols Plasma Derived Medicine Product and Services
Table 16. Grifols Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Grifols Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Plasma Derived Medicine Product and Services
Table 21. Octapharma Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Octapharma Recent Developments/Updates
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma Derived Medicine Product and Services
Table 26. Kedrion Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Kedrion Recent Developments/Updates
Table 28. LFB Group Basic Information, Manufacturing Base and Competitors
Table 29. LFB Group Major Business
Table 30. LFB Group Plasma Derived Medicine Product and Services
Table 31. LFB Group Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. LFB Group Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Plasma Derived Medicine Product and Services
Table 36. Biotest Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biotest Recent Developments/Updates
Table 38. BPL Basic Information, Manufacturing Base and Competitors
Table 39. BPL Major Business
Table 40. BPL Plasma Derived Medicine Product and Services
Table 41. BPL Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. BPL Recent Developments/Updates
Table 43. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai RAAS Major Business
Table 45. Shanghai RAAS Plasma Derived Medicine Product and Services
Table 46. Shanghai RAAS Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Shanghai RAAS Recent Developments/Updates
Table 48. China Biologic Products Basic Information, Manufacturing Base and Competitors
Table 49. China Biologic Products Major Business
Table 50. China Biologic Products Plasma Derived Medicine Product and Services
Table 51. China Biologic Products Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. China Biologic Products Recent Developments/Updates
Table 53. Hualan Biological Engineering Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Biological Engineering Inc. Major Business
Table 55. Hualan Biological Engineering Inc. Plasma Derived Medicine Product and Services
Table 56. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hualan Biological Engineering Inc. Recent Developments/Updates
Table 58. Beijing Tiantan Biological Products Corp Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Tiantan Biological Products Corp Major Business
Table 60. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product and Services
Table 61. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Beijing Tiantan Biological Products Corp Recent Developments/Updates
Table 63. Pacific Shuanglin Basic Information, Manufacturing Base and Competitors
Table 64. Pacific Shuanglin Major Business
Table 65. Pacific Shuanglin Plasma Derived Medicine Product and Services
Table 66. Pacific Shuanglin Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Pacific Shuanglin Recent Developments/Updates
Table 68. Boya Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Boya Bio-Pharmaceutical Major Business
Table 70. Boya Bio-Pharmaceutical Plasma Derived Medicine Product and Services
Table 71. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Boya Bio-Pharmaceutical Recent Developments/Updates
Table 73. Paisi Feike Biology Pharmacy Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Paisi Feike Biology Pharmacy Co., Ltd. Major Business
Table 75. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product and Services
Table 76. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
Table 78. Xinjiang Deyuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 79. Xinjiang Deyuan Bioengineering Major Business
Table 80. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product and Services
Table 81. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Xinjiang Deyuan Bioengineering Recent Developments/Updates
Table 83. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Major Business
Table 85. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product and Services
Table 86. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Shenzhen Weiguang Basic Information, Manufacturing Base and Competitors
Table 89. Shenzhen Weiguang Major Business
Table 90. Shenzhen Weiguang Plasma Derived Medicine Product and Services
Table 91. Shenzhen Weiguang Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Shenzhen Weiguang Recent Developments/Updates
Table 93. Shanxi Kangbao Basic Information, Manufacturing Base and Competitors
Table 94. Shanxi Kangbao Major Business
Table 95. Shanxi Kangbao Plasma Derived Medicine Product and Services
Table 96. Shanxi Kangbao Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Shanxi Kangbao Recent Developments/Updates
Table 98. Nanyue Biopharming Corporation Ltd Basic Information, Manufacturing Base and Competitors
Table 99. Nanyue Biopharming Corporation Ltd Major Business
Table 100. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product and Services
Table 101. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Nanyue Biopharming Corporation Ltd Recent Developments/Updates
Table 103. Global Plasma Derived Medicine Sales Quantity by Manufacturer (2019-2024) & (K Bottles)
Table 104. Global Plasma Derived Medicine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 105. Global Plasma Derived Medicine Average Price by Manufacturer (2019-2024) & (USD/Bottle)
Table 106. Market Position of Manufacturers in Plasma Derived Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 107. Head Office and Plasma Derived Medicine Production Site of Key Manufacturer
Table 108. Plasma Derived Medicine Market: Company Product Type Footprint
Table 109. Plasma Derived Medicine Market: Company Product Application Footprint
Table 110. Plasma Derived Medicine New Market Entrants and Barriers to Market Entry
Table 111. Plasma Derived Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Plasma Derived Medicine Sales Quantity by Region (2019-2024) & (K Bottles)
Table 113. Global Plasma Derived Medicine Sales Quantity by Region (2025-2030) & (K Bottles)
Table 114. Global Plasma Derived Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 115. Global Plasma Derived Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 116. Global Plasma Derived Medicine Average Price by Region (2019-2024) & (USD/Bottle)
Table 117. Global Plasma Derived Medicine Average Price by Region (2025-2030) & (USD/Bottle)
Table 118. Global Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 119. Global Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 120. Global Plasma Derived Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Global Plasma Derived Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Global Plasma Derived Medicine Average Price by Type (2019-2024) & (USD/Bottle)
Table 123. Global Plasma Derived Medicine Average Price by Type (2025-2030) & (USD/Bottle)
Table 124. Global Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 125. Global Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 126. Global Plasma Derived Medicine Consumption Value by Application (2019-2024) & (USD Million)
Table 127. Global Plasma Derived Medicine Consumption Value by Application (2025-2030) & (USD Million)
Table 128. Global Plasma Derived Medicine Average Price by Application (2019-2024) & (USD/Bottle)
Table 129. Global Plasma Derived Medicine Average Price by Application (2025-2030) & (USD/Bottle)
Table 130. North America Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 131. North America Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 132. North America Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 133. North America Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 134. North America Plasma Derived Medicine Sales Quantity by Country (2019-2024) & (K Bottles)
Table 135. North America Plasma Derived Medicine Sales Quantity by Country (2025-2030) & (K Bottles)
Table 136. North America Plasma Derived Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 137. North America Plasma Derived Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Europe Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 139. Europe Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 140. Europe Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 141. Europe Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 142. Europe Plasma Derived Medicine Sales Quantity by Country (2019-2024) & (K Bottles)
Table 143. Europe Plasma Derived Medicine Sales Quantity by Country (2025-2030) & (K Bottles)
Table 144. Europe Plasma Derived Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Plasma Derived Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 147. Asia-Pacific Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 148. Asia-Pacific Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 149. Asia-Pacific Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 150. Asia-Pacific Plasma Derived Medicine Sales Quantity by Region (2019-2024) & (K Bottles)
Table 151. Asia-Pacific Plasma Derived Medicine Sales Quantity by Region (2025-2030) & (K Bottles)
Table 152. Asia-Pacific Plasma Derived Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 153. Asia-Pacific Plasma Derived Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 154. South America Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 155. South America Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 156. South America Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 157. South America Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 158. South America Plasma Derived Medicine Sales Quantity by Country (2019-2024) & (K Bottles)
Table 159. South America Plasma Derived Medicine Sales Quantity by Country (2025-2030) & (K Bottles)
Table 160. South America Plasma Derived Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 161. South America Plasma Derived Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 162. Middle East & Africa Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 163. Middle East & Africa Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 164. Middle East & Africa Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 165. Middle East & Africa Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 166. Middle East & Africa Plasma Derived Medicine Sales Quantity by Region (2019-2024) & (K Bottles)
Table 167. Middle East & Africa Plasma Derived Medicine Sales Quantity by Region (2025-2030) & (K Bottles)
Table 168. Middle East & Africa Plasma Derived Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 169. Middle East & Africa Plasma Derived Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 170. Plasma Derived Medicine Raw Material
Table 171. Key Manufacturers of Plasma Derived Medicine Raw Materials
Table 172. Plasma Derived Medicine Typical Distributors
Table 173. Plasma Derived Medicine Typical Customers
Table 1. Global Plasma Derived Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Plasma Derived Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma Derived Medicine Product and Services
Table 6. Takeda Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Plasma Derived Medicine Product and Services
Table 11. CSL Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Recent Developments/Updates
Table 13. Grifols Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Major Business
Table 15. Grifols Plasma Derived Medicine Product and Services
Table 16. Grifols Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Grifols Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Plasma Derived Medicine Product and Services
Table 21. Octapharma Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Octapharma Recent Developments/Updates
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma Derived Medicine Product and Services
Table 26. Kedrion Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Kedrion Recent Developments/Updates
Table 28. LFB Group Basic Information, Manufacturing Base and Competitors
Table 29. LFB Group Major Business
Table 30. LFB Group Plasma Derived Medicine Product and Services
Table 31. LFB Group Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. LFB Group Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Plasma Derived Medicine Product and Services
Table 36. Biotest Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biotest Recent Developments/Updates
Table 38. BPL Basic Information, Manufacturing Base and Competitors
Table 39. BPL Major Business
Table 40. BPL Plasma Derived Medicine Product and Services
Table 41. BPL Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. BPL Recent Developments/Updates
Table 43. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai RAAS Major Business
Table 45. Shanghai RAAS Plasma Derived Medicine Product and Services
Table 46. Shanghai RAAS Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Shanghai RAAS Recent Developments/Updates
Table 48. China Biologic Products Basic Information, Manufacturing Base and Competitors
Table 49. China Biologic Products Major Business
Table 50. China Biologic Products Plasma Derived Medicine Product and Services
Table 51. China Biologic Products Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. China Biologic Products Recent Developments/Updates
Table 53. Hualan Biological Engineering Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Biological Engineering Inc. Major Business
Table 55. Hualan Biological Engineering Inc. Plasma Derived Medicine Product and Services
Table 56. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hualan Biological Engineering Inc. Recent Developments/Updates
Table 58. Beijing Tiantan Biological Products Corp Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Tiantan Biological Products Corp Major Business
Table 60. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product and Services
Table 61. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Beijing Tiantan Biological Products Corp Recent Developments/Updates
Table 63. Pacific Shuanglin Basic Information, Manufacturing Base and Competitors
Table 64. Pacific Shuanglin Major Business
Table 65. Pacific Shuanglin Plasma Derived Medicine Product and Services
Table 66. Pacific Shuanglin Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Pacific Shuanglin Recent Developments/Updates
Table 68. Boya Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Boya Bio-Pharmaceutical Major Business
Table 70. Boya Bio-Pharmaceutical Plasma Derived Medicine Product and Services
Table 71. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Boya Bio-Pharmaceutical Recent Developments/Updates
Table 73. Paisi Feike Biology Pharmacy Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Paisi Feike Biology Pharmacy Co., Ltd. Major Business
Table 75. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product and Services
Table 76. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
Table 78. Xinjiang Deyuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 79. Xinjiang Deyuan Bioengineering Major Business
Table 80. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product and Services
Table 81. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Xinjiang Deyuan Bioengineering Recent Developments/Updates
Table 83. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Major Business
Table 85. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product and Services
Table 86. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Shenzhen Weiguang Basic Information, Manufacturing Base and Competitors
Table 89. Shenzhen Weiguang Major Business
Table 90. Shenzhen Weiguang Plasma Derived Medicine Product and Services
Table 91. Shenzhen Weiguang Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Shenzhen Weiguang Recent Developments/Updates
Table 93. Shanxi Kangbao Basic Information, Manufacturing Base and Competitors
Table 94. Shanxi Kangbao Major Business
Table 95. Shanxi Kangbao Plasma Derived Medicine Product and Services
Table 96. Shanxi Kangbao Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Shanxi Kangbao Recent Developments/Updates
Table 98. Nanyue Biopharming Corporation Ltd Basic Information, Manufacturing Base and Competitors
Table 99. Nanyue Biopharming Corporation Ltd Major Business
Table 100. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product and Services
Table 101. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales Quantity (K Bottles), Average Price (USD/Bottle), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Nanyue Biopharming Corporation Ltd Recent Developments/Updates
Table 103. Global Plasma Derived Medicine Sales Quantity by Manufacturer (2019-2024) & (K Bottles)
Table 104. Global Plasma Derived Medicine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 105. Global Plasma Derived Medicine Average Price by Manufacturer (2019-2024) & (USD/Bottle)
Table 106. Market Position of Manufacturers in Plasma Derived Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 107. Head Office and Plasma Derived Medicine Production Site of Key Manufacturer
Table 108. Plasma Derived Medicine Market: Company Product Type Footprint
Table 109. Plasma Derived Medicine Market: Company Product Application Footprint
Table 110. Plasma Derived Medicine New Market Entrants and Barriers to Market Entry
Table 111. Plasma Derived Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Plasma Derived Medicine Sales Quantity by Region (2019-2024) & (K Bottles)
Table 113. Global Plasma Derived Medicine Sales Quantity by Region (2025-2030) & (K Bottles)
Table 114. Global Plasma Derived Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 115. Global Plasma Derived Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 116. Global Plasma Derived Medicine Average Price by Region (2019-2024) & (USD/Bottle)
Table 117. Global Plasma Derived Medicine Average Price by Region (2025-2030) & (USD/Bottle)
Table 118. Global Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 119. Global Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 120. Global Plasma Derived Medicine Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Global Plasma Derived Medicine Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Global Plasma Derived Medicine Average Price by Type (2019-2024) & (USD/Bottle)
Table 123. Global Plasma Derived Medicine Average Price by Type (2025-2030) & (USD/Bottle)
Table 124. Global Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 125. Global Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 126. Global Plasma Derived Medicine Consumption Value by Application (2019-2024) & (USD Million)
Table 127. Global Plasma Derived Medicine Consumption Value by Application (2025-2030) & (USD Million)
Table 128. Global Plasma Derived Medicine Average Price by Application (2019-2024) & (USD/Bottle)
Table 129. Global Plasma Derived Medicine Average Price by Application (2025-2030) & (USD/Bottle)
Table 130. North America Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 131. North America Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 132. North America Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 133. North America Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 134. North America Plasma Derived Medicine Sales Quantity by Country (2019-2024) & (K Bottles)
Table 135. North America Plasma Derived Medicine Sales Quantity by Country (2025-2030) & (K Bottles)
Table 136. North America Plasma Derived Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 137. North America Plasma Derived Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Europe Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 139. Europe Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 140. Europe Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 141. Europe Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 142. Europe Plasma Derived Medicine Sales Quantity by Country (2019-2024) & (K Bottles)
Table 143. Europe Plasma Derived Medicine Sales Quantity by Country (2025-2030) & (K Bottles)
Table 144. Europe Plasma Derived Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Plasma Derived Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 147. Asia-Pacific Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 148. Asia-Pacific Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 149. Asia-Pacific Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 150. Asia-Pacific Plasma Derived Medicine Sales Quantity by Region (2019-2024) & (K Bottles)
Table 151. Asia-Pacific Plasma Derived Medicine Sales Quantity by Region (2025-2030) & (K Bottles)
Table 152. Asia-Pacific Plasma Derived Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 153. Asia-Pacific Plasma Derived Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 154. South America Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 155. South America Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 156. South America Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 157. South America Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 158. South America Plasma Derived Medicine Sales Quantity by Country (2019-2024) & (K Bottles)
Table 159. South America Plasma Derived Medicine Sales Quantity by Country (2025-2030) & (K Bottles)
Table 160. South America Plasma Derived Medicine Consumption Value by Country (2019-2024) & (USD Million)
Table 161. South America Plasma Derived Medicine Consumption Value by Country (2025-2030) & (USD Million)
Table 162. Middle East & Africa Plasma Derived Medicine Sales Quantity by Type (2019-2024) & (K Bottles)
Table 163. Middle East & Africa Plasma Derived Medicine Sales Quantity by Type (2025-2030) & (K Bottles)
Table 164. Middle East & Africa Plasma Derived Medicine Sales Quantity by Application (2019-2024) & (K Bottles)
Table 165. Middle East & Africa Plasma Derived Medicine Sales Quantity by Application (2025-2030) & (K Bottles)
Table 166. Middle East & Africa Plasma Derived Medicine Sales Quantity by Region (2019-2024) & (K Bottles)
Table 167. Middle East & Africa Plasma Derived Medicine Sales Quantity by Region (2025-2030) & (K Bottles)
Table 168. Middle East & Africa Plasma Derived Medicine Consumption Value by Region (2019-2024) & (USD Million)
Table 169. Middle East & Africa Plasma Derived Medicine Consumption Value by Region (2025-2030) & (USD Million)
Table 170. Plasma Derived Medicine Raw Material
Table 171. Key Manufacturers of Plasma Derived Medicine Raw Materials
Table 172. Plasma Derived Medicine Typical Distributors
Table 173. Plasma Derived Medicine Typical Customers
LIST OF FIGURES
Figure 1. Plasma Derived Medicine Picture
Figure 2. Global Plasma Derived Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Plasma Derived Medicine Consumption Value Market Share by Type in 2023
Figure 4. Albumin Examples
Figure 5. Immune Globulin Examples
Figure 6. Coagulation Factor Examples
Figure 7. Others Examples
Figure 8. Global Plasma Derived Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Plasma Derived Medicine Consumption Value Market Share by Application in 2023
Figure 10. Bleeding Wound Examples
Figure 11. Immunodeficiency Examples
Figure 12. HBV Examples
Figure 13. Tetanus Examples
Figure 14. Rabies Examples
Figure 15. Hemophilia Examples
Figure 16. Others Examples
Figure 17. Global Plasma Derived Medicine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Plasma Derived Medicine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Plasma Derived Medicine Sales Quantity (2019-2030) & (K Bottles)
Figure 20. Global Plasma Derived Medicine Average Price (2019-2030) & (USD/Bottle)
Figure 21. Global Plasma Derived Medicine Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Plasma Derived Medicine Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Plasma Derived Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Plasma Derived Medicine Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Plasma Derived Medicine Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Plasma Derived Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Plasma Derived Medicine Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Plasma Derived Medicine Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Plasma Derived Medicine Average Price by Type (2019-2030) & (USD/Bottle)
Figure 36. Global Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Plasma Derived Medicine Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Plasma Derived Medicine Average Price by Application (2019-2030) & (USD/Bottle)
Figure 39. North America Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Plasma Derived Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Plasma Derived Medicine Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Plasma Derived Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Plasma Derived Medicine Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Plasma Derived Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Plasma Derived Medicine Consumption Value Market Share by Region (2019-2030)
Figure 59. China Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Plasma Derived Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Plasma Derived Medicine Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Plasma Derived Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Plasma Derived Medicine Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Plasma Derived Medicine Market Drivers
Figure 80. Plasma Derived Medicine Market Restraints
Figure 81. Plasma Derived Medicine Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Plasma Derived Medicine in 2023
Figure 84. Manufacturing Process Analysis of Plasma Derived Medicine
Figure 85. Plasma Derived Medicine Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
Figure 1. Plasma Derived Medicine Picture
Figure 2. Global Plasma Derived Medicine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Plasma Derived Medicine Consumption Value Market Share by Type in 2023
Figure 4. Albumin Examples
Figure 5. Immune Globulin Examples
Figure 6. Coagulation Factor Examples
Figure 7. Others Examples
Figure 8. Global Plasma Derived Medicine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Plasma Derived Medicine Consumption Value Market Share by Application in 2023
Figure 10. Bleeding Wound Examples
Figure 11. Immunodeficiency Examples
Figure 12. HBV Examples
Figure 13. Tetanus Examples
Figure 14. Rabies Examples
Figure 15. Hemophilia Examples
Figure 16. Others Examples
Figure 17. Global Plasma Derived Medicine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Plasma Derived Medicine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Plasma Derived Medicine Sales Quantity (2019-2030) & (K Bottles)
Figure 20. Global Plasma Derived Medicine Average Price (2019-2030) & (USD/Bottle)
Figure 21. Global Plasma Derived Medicine Sales Quantity Market Share by Manufacturer in 2023
Figure 22. Global Plasma Derived Medicine Consumption Value Market Share by Manufacturer in 2023
Figure 23. Producer Shipments of Plasma Derived Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 24. Top 3 Plasma Derived Medicine Manufacturer (Consumption Value) Market Share in 2023
Figure 25. Top 6 Plasma Derived Medicine Manufacturer (Consumption Value) Market Share in 2023
Figure 26. Global Plasma Derived Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 27. Global Plasma Derived Medicine Consumption Value Market Share by Region (2019-2030)
Figure 28. North America Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 29. Europe Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 30. Asia-Pacific Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 31. South America Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 32. Middle East & Africa Plasma Derived Medicine Consumption Value (2019-2030) & (USD Million)
Figure 33. Global Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Plasma Derived Medicine Consumption Value Market Share by Type (2019-2030)
Figure 35. Global Plasma Derived Medicine Average Price by Type (2019-2030) & (USD/Bottle)
Figure 36. Global Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Plasma Derived Medicine Consumption Value Market Share by Application (2019-2030)
Figure 38. Global Plasma Derived Medicine Average Price by Application (2019-2030) & (USD/Bottle)
Figure 39. North America Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 41. North America Plasma Derived Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 42. North America Plasma Derived Medicine Consumption Value Market Share by Country (2019-2030)
Figure 43. United States Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Canada Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. Mexico Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Europe Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 47. Europe Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 48. Europe Plasma Derived Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 49. Europe Plasma Derived Medicine Consumption Value Market Share by Country (2019-2030)
Figure 50. Germany Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. France Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. United Kingdom Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Russia Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Italy Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Asia-Pacific Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 56. Asia-Pacific Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 57. Asia-Pacific Plasma Derived Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 58. Asia-Pacific Plasma Derived Medicine Consumption Value Market Share by Region (2019-2030)
Figure 59. China Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Japan Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Korea Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. India Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Southeast Asia Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Australia Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. South America Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 66. South America Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 67. South America Plasma Derived Medicine Sales Quantity Market Share by Country (2019-2030)
Figure 68. South America Plasma Derived Medicine Consumption Value Market Share by Country (2019-2030)
Figure 69. Brazil Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Argentina Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Middle East & Africa Plasma Derived Medicine Sales Quantity Market Share by Type (2019-2030)
Figure 72. Middle East & Africa Plasma Derived Medicine Sales Quantity Market Share by Application (2019-2030)
Figure 73. Middle East & Africa Plasma Derived Medicine Sales Quantity Market Share by Region (2019-2030)
Figure 74. Middle East & Africa Plasma Derived Medicine Consumption Value Market Share by Region (2019-2030)
Figure 75. Turkey Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Egypt Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Saudi Arabia Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 78. South Africa Plasma Derived Medicine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 79. Plasma Derived Medicine Market Drivers
Figure 80. Plasma Derived Medicine Market Restraints
Figure 81. Plasma Derived Medicine Market Trends
Figure 82. Porters Five Forces Analysis
Figure 83. Manufacturing Cost Structure Analysis of Plasma Derived Medicine in 2023
Figure 84. Manufacturing Process Analysis of Plasma Derived Medicine
Figure 85. Plasma Derived Medicine Industrial Chain
Figure 86. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 87. Direct Channel Pros & Cons
Figure 88. Indirect Channel Pros & Cons
Figure 89. Methodology
Figure 90. Research Process and Data Source
